MECR and Parkinson disease: The identification of allosteric sites on MECR, and subsequent virtual screening of candidate activators, have highlighted compounds with potential modulatory effects on MECR activity, suggesting their promise for further investigation as the therapeutic candidates aimed at restoring mitochondrial function in PD.